# Yoon Kyung Jeon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yoon-kyung-jeon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,725 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 63 |
| i10-index | 212 |
| Last Known Institution | Seoul National University |
| OpenAlex ID | https://openalex.org/A5070098382 |
| ORCID iD | 0000-0001-8466-9681 |
| Works | 486 |

## Researcher papers

- [Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas](https://scholariq.org/papers/clonal-history-and-genetic-predictors-of-transformation-into-small-cell/)
- [Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration](https://scholariq.org/papers/pan-cancer-immunogenomic-perspective-on-the-tumor-microenvironment-based-on-pd/)
- [Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis](https://scholariq.org/papers/tumor-associated-macrophages-enhance-tumor-hypoxia-and-aerobic-glycolysis/)
- [Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation](https://scholariq.org/papers/optimization-of-patient-selection-for-gefitinib-in-non-small-cell-lung-cancer-by/)
- [Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial](https://scholariq.org/papers/vandetanib-in-pretreated-patients-with-advanced-non-small-cell-lung-cancer/)
- [Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma](https://scholariq.org/papers/tracing-oncogene-rearrangements-in-the-mutational-history-of-lung-adenocarcinoma/)
- [Frequent detection of <scp><i>BRAF</i><sup>V</sup></scp><sup>600E</sup> mutations in histiocytic and dendritic cell neoplasms](https://scholariq.org/papers/frequent-detection-of-scp-i-braf-i-sup-v-sup-scp-sup-600e-sup-mutations-in/)
- [Mechanisms of Acquired Resistance to AZD9291](https://scholariq.org/papers/mechanisms-of-acquired-resistance-to-azd9291/)
- [High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer](https://scholariq.org/papers/high-met-gene-copy-number-leads-to-shorter-survival-in-patients-with-non-small/)
- [Psat1-Dependent Fluctuations in α-Ketoglutarate Affect the Timing of ESC Differentiation](https://scholariq.org/papers/psat1-dependent-fluctuations-in-ketoglutarate-affect-the-timing-of-esc/)
- [Treatment strategies based on the molecular subtypes of transformed small cell lung cancer (t-SCLC)](https://scholariq.org/papers/treatment-strategies-based-on-the-molecular-subtypes-of-transformed-small-cell/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Seoul National University](https://scholariq.org/institutions/seoul-national-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.